Haoxi Health Technology (NASDAQ:HAO) Cut to “Sell” at Wall Street Zen

Wall Street Zen downgraded shares of Haoxi Health Technology (NASDAQ:HAO) from a hold rating to a sell rating in a research report report published on Sunday morning.

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Haoxi Health Technology in a report on Friday, July 17th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

Haoxi Health Technology Trading Up 15.9%

Shares of Haoxi Health Technology stock opened at $3.49 on Friday. Haoxi Health Technology has a 52-week low of $2.70 and a 52-week high of $5,708.80. The stock has a 50-day simple moving average of $9.87 and a 200-day simple moving average of $1,303.87.

About Haoxi Health Technology

Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo.